Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
96.3M
-
Shares change
-
-851K
-
Total reported value, excl. options
-
$3.2B
-
Value change
-
-$41.7M
-
Put/Call ratio
-
0.78
-
Number of buys
-
98
-
Number of sells
-
-116
-
Price
-
$33.28
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q3 2021
288 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q3 2021.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96.3M shares
of 157M outstanding shares and own 61.23% of the company stock.
Largest 10 shareholders include FMR LLC (19.3M shares), VANGUARD GROUP INC (12M shares), BlackRock Inc. (8.86M shares), STATE STREET CORP (4.3M shares), Capital World Investors (4.17M shares), RA CAPITAL MANAGEMENT, L.P. (4.1M shares), ALKEON CAPITAL MANAGEMENT LLC (4.07M shares), MAVERICK CAPITAL LTD (3.3M shares), PICTET ASSET MANAGEMENT SA (2.45M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.3M shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.